Showing results (1-10 of 482) with videos related to
Sort By:
Pageof 49
Nature Reviews. Microbiology|March 15, 2023
Crimean-Congo haemorrhagic fever virusDavid W Hawman, Heinz FeldmannF1000Research|November 13, 2018
Recent advances in understanding Crimean-Congo hemorrhagic fever virusDavid W Hawman, Heinz FeldmannViruses|March 6, 2021
A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) ProteinsShanna S Leventhal, Drew Wilson, Heinz Feldmann, et al.Microorganisms|June 2, 2021
An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian HamstersShanna S Leventhal, Chad Clancy, Jesse Erasmus, et al.Ebiomedicine|October 22, 2023
CD8+ T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type miceDeepashri Rao, Kimberly Meade-White, Shanna Leventhal, et al.Microorganisms|February 12, 2021
T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in MiceDavid W Hawman, Kimberly Meade-White, Shanna Leventhal, et al.Antiviral Research|August 23, 2023
Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infectionThomas Tipih, Kimberly Meade-White, Deepashri Rao, et al.Elife|January 8, 2021
Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virusDavid W Hawman, Kimberly Meade-White, Shanna Leventhal, et al.Journal of Virology|July 12, 2019
Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human ConvalescenceDavid W Hawman, Kimberly Meade-White, Elaine Haddock, et al.NPJ Vaccines|December 20, 2024
Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in miceShanna S Leventhal, Carl Shaia, Deepashri Rao, et al.Pageof 49